HWAM
NVAX icon

Hennion & Walsh Asset Management’s Novavax NVAX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,135
Closed -$67.6K – 886
2024
Q1 		$67.6K Buy
14,135
+940
+7% +$4.36K ﹤0.01% 839
2023
Q4 		$63.3K Buy
13,195
+1,615
+14% +$9.89K ﹤0.01% 813
2023
Q3 		$83.8K Buy
11,580
+459
+4% +$3.67K 0.01% 788
2023
Q2 		$83K Sell
11,121
-301
-3% -$2.37K ﹤0.01% 790
2023
Q1 		$79K Sell
11,422
-361
-3% -$3.32K ﹤0.01% 763
2022
Q4 		$121K Buy
11,783
+1,472
+14% +$26K 0.01% 753
2022
Q3 		$188K Buy
10,311
+2,570
+33% +$111K 0.01% 721
2022
Q2 		$398K Buy
+7,741
New +$401K 0.02% 541

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Hennion & Walsh Asset Management's NVAX Position: Q2 2024 in Review

Hennion & Walsh Asset Management sold out of Novavax (NVAX) in Q2 2024, closing a stake of 14,135 shares — an estimated $67.6K sold.

Hennion & Walsh Asset Management first reported a position in NVAX in Q2 2022 and held it in 8 quarters. The position peaked at $398K in Q2 2022. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Hennion & Walsh Asset Management reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 14,135 Novavax shares in Q2 2024, an estimated $67.6K.
  • Hennion & Walsh Asset Management first reported a position in Novavax in Q2 2022 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's Novavax position peaked at $398K in Q2 2022.
  • 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.